Search Results

(1R,2’R,4E,5’S,6S,6’S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,28S,29R)-22-Ethyl-7,11,14,15-tetrahydroxy-6′-((R)-2-hydroxypropyl)-5′,6,8,10,12,14,16,28,29-nonamethyl-3′,4′,5′,6′-tetrahydro-2,26-dioxaspiro[bicyclo[23.3.1]nonacosa[4,18,20]triene-27,2′-pyran]-3,9,13-trione 100mg  | 95%

BLD Pharmatech Ltd.

(1R,2R,3aS,9aS)-1-[(S)-3-Hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalene-2,5-diol Please inquire  | Purity Not Available

BOC Sciences

(1R,2R,3aS,9aS)-1-[(S)-3-Hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalene-2,5-diol (CAS# 101692-02-8) is an impurity in the synthesis of Treprostinil (T719500), Synthetic analog of Prostacyclin (P839060). Antihypertensive. Treprostinil, marketed under the trade name Remodulin is a medication used to treat pulmonary arterial hypertension (PAH).

More Information Supplier Page